William A. Hall, MD

Publications

• Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group.

  (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA.) Eur J Cancer. 2021 Aug;153:64-71 PMID: 34144436 06/19/2021

• Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.

  (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, Moxley KM, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ.) JAMA Oncol. 2021 Jul 01 PMID: 34196693 PMCID: PMC8251652 07/02/2021

• Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

  (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2021 07;222(1):10-17 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020

• In Reply to Onal et al.

  (Hall WA, Lawton CAF, coauthors.) Int J Radiat Oncol Biol Phys. 2021 Jun 01;110(2):620-621 PMID: 33989589 SCOPUS ID: 2-s2.0-85105339930 05/15/2021

• The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?

  (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C.) Clin Transl Radiat Oncol. 2021 May;28:124-128 PMID: 33981865 PMCID: PMC8085778 05/14/2021

• Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.

  (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF.) Pract Radiat Oncol. 2021 Apr 10 PMID: 33848618 SCOPUS ID: 2-s2.0-85107984420 04/14/2021

• Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.

  (Feng FY, Huang HC, Spratt DE, Zhao SG, Sandler HM, Simko JP, Davicioni E, Nguyen PL, Pollack A, Efstathiou JA, Dicker AP, Todorovic T, Margrave J, Liu YS, Dabbas B, Thompson DJS, Das R, Dignam JJ, Sweeney C, Attard G, Bahary JP, Lukka HR, Hall WA, Pisansky TM, Shah AB, Pugh SL, Shipley WU, Tran PT.) JAMA Oncol. 2021 Apr 01;7(4):544-552 PMID: 33570548 PMCID: PMC7879385 SCOPUS ID: 2-s2.0-85100750925 02/12/2021

• Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group

  (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA.) European Journal of Cancer. August 2021;153:64-71 SCOPUS ID: 2-s2.0-85107945729 08/01/2021

• Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage

  (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR.) Clinical Genitourinary Cancer. June 2021;19(3):267-270.e1 SCOPUS ID: 2-s2.0-85096167136 06/01/2021

• Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions.

  (Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA.) Front Oncol. 2021;11:628155 PMID: 34046339 PMCID: PMC8144850 SCOPUS ID: 2-s2.0-85107182435 05/29/2021

• Considering benefit and risk before routinely recommending SpaceOAR.

  (Hall WA, Tree AC, Dearnaley D, Parker CC, Prasad V, Roach M 3rd, Lawton CAF.) Lancet Oncol. 2021 01;22(1):11-13 PMID: 33387489 SCOPUS ID: 2-s2.0-85098657879 01/03/2021